Newsroom | 4185 results

NASHVILLE, Tenn.--(BUSINESS WIRE)--Heritage Group, a healthcare-focused private equity firm, today announced the final closing of Heritage Healthcare Innovation Fund IV (“Fund IV” or the “Fund”) at over $370 million, marking another significant milestone in the firm’s continued growth. Fund IV builds on Heritage Group’s successful strategy of making minority and majority investments in solution-oriented, high-growth healthcare services and technology businesses that address the industry’s most...

ANDOVER, Mass. & HAIFA, Israel--(BUSINESS WIRE)--MeMed BV Flex test differentiates between bacterial and viral infection in 15 minutes using only a few drops of capillary blood from a finger prick....

SAN FRANCISCO--(BUSINESS WIRE)--Olto, the AI demo engineer transforming how B2B teams demo and sell software, has raised $5.1 million in pre-seed funding. The round was co-led by Nexus Venture Partners and The General Partnership, with participation from Afore Capital, Recall Capital, Ligature, FirstHand and notable founders and executives. Olto transforms every buyer interaction, whether a live demo call, an outbound touch, or an inbound visit, into a high-converting product experience by gene...

ATLANTA--(BUSINESS WIRE)--Generative AI and agentic AI represent the greatest business transformation opportunity in decades, yet most companies are looking for expertise to capture it. Building capabilities in-house takes too long, while off-the-shelf solutions lack critical industry-specific nuances. Today, StellarIQ launched to provide a better path: combining investment capital and operational experience with a proven generative AI platform. Leveraging a Comprehensive AI Transformation Mode...

MINNEAPOLIS--(BUSINESS WIRE)--Datasite®, the global SaaS provider of Al-powered workflow collaboration and automation solutions for M&A, investment and strategic projects, today announced that it has acquired Blueflame Al™, a leading provider of agentic Al solutions for investment and financial services. Terms of the deal are not being disclosed. “This acquisition continues Datasite's mission to improve the velocity and outcomes of our clients’ projects. Blueflame's agentic Al solutions wil...

HENDERSON, Nev.--(BUSINESS WIRE)--Corstasis Therapeutics Inc. (www.corstasis.com), a late clinical-stage innovator of therapies that enhance options for the treatment of fluid overload in patients with cardiorenal and hepatic diseases, with the intent of lowering the overall cost of care, today announced that life science executive Sanjeev Narula has joined the company’s Strategic Advisory Board. “Sanjeev’s extensive strategic, financial and operational experience in large commercial-stage phar...

PORTLAND, Ore.--(BUSINESS WIRE)--The State of Oregon invested $3M in Meriwether Group Capital’s Hero Fund after a comprehensive diligence process led by Meketa Investment Group....

NOOSAVILLE, Australia--(BUSINESS WIRE)--Provectus Algae raises $10.1M in Series A financing & $2.5M in grant funding from the Australian government for its methane-reducing feed supplement...

NEW YORK--(BUSINESS WIRE)--Fortuna Health, the leading consumer Medicaid navigation platform, announced it has raised $18 million in Series A funding. The round was led by returning investors Andreessen Horowitz with participation from Y Combinator and founders and executives from Abridge, DoorDash, Hex, One Medical, Oscar Health, Scale, and Vanta. The funding will accelerate Fortuna’s investments in AI-powered workflows, fuel expansion into new states, and help scale infrastructure to meet sur...

NEW YORK--(BUSINESS WIRE)--Lerer Hippeau, a leading early stage venture capital firm founded and operated in New York City, announced today that it has hired Ron Zori as Venture Partner - the first in the firm’s history - for Fund IX. Fund IX, a $200M fund focused exclusively on early stage investments, also marks 15 years of Lerer Hippeau supporting early stage founders by serving as their first and most aligned institutional partner. Zori joins LH after a decade of operating and investing in...